Annovis Bio, Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.44 | $-0.40 | +9.1% | Beat |
| Q22026 FY2026 | $-0.44 | $-0.32 | +27.3% | Beat |
| Q12026 FY2026 | — | $-0.63 | — | Miss |
| Q42025 FY2025 | — | $-0.39 | — | Miss |
Back to ANVS overview · ANVS holders · ANVS KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.